Cited by 1,560Cerebrospinal fluid and hydrocephalusIon Transport and Channel RegulationAlzheimer's disease research and treatments

The glymphatic pathway in neurological disorders.

Open access
Rasmussen, Martin Kaag, Mestre, Humberto, Nedergaard, Maiken·2018·The Lancet Neurology

Abstract

Background The glymphatic (glial-lymphatic) pathway is a fluid-clearance pathway identified in the rodent brain in 2012. This pathway subserves the flow of CSF into the brain along arterial perivascular spaces and subsequently into the brain interstitium, facilitated by aquaporin 4 (AQP4) water channels. The pathway then directs flow towards the venous perivascular and perineuronal spaces, ultimately clearing solutes from the neuropil into meningeal and cervical lymphatic drainage vessels. In rodents, the glymphatic pathway is predominantly active during sleep, when the clearance of harmful metabolites such as amyloid β (Aβ) increases two-fold relative to the waking state. Glymphatic dysfunction, probably related to perturbed AQP4 expression, has been shown in animal models of traumatic brain injury, Alzheimer's disease, and stroke. The recent characterisations of the glymphatic and meningeal lymphatic systems in rodents and in humans call for revaluation of the anatomical routes for CSF-interstitial fluid flow and the physiological role that these pathways play in CNS health.Recent developments Several features of the glymphatic and meningeal lymphatic systems have been shown to be present in humans. MRI scans with intrathecally administered contrast agent show that CSF flows along pathways that closely resemble the glymphatic system outlined in rodents. Furthermore, PET studies have revealed that Aβ accumulates in the healthy brain after a single night of sleep deprivation, suggesting that the human glymphatic pathway might also be primarily active during sleep. Other PET studies have shown that CSF clearance of Aβ and tau tracers is reduced in patients with Alzheimer's disease compared with healthy controls. The observed reduction in CSF clearance was associated with increasing grey-matter concentrations of Aβ in the human brain, consistent with findings in mice showing that decreased glymphatic function leads to Aβ accumulation. Altered AQP4 expression is also evident in brain tissue from patients with Alzheimer's disease or normal pressure hydrocephalus; glymphatic MRI scans of patients with normal pressure hydrocephalus show reduced CSF tracer entry and clearance. WHERE NEXT?: Research is needed to confirm whether specific factors driving glymphatic flow in rodents also apply to humans. Longitudinal imaging studies evaluating human CSF dynamics will determine whether a causal link exists between reduced brain solute clearance and the development of neurodegenerative diseases. Assessment of glymphatic function after stroke or traumatic brain injury could identify whether this function correlates with neurological recovery. New insights into how behaviour and genetics modify glymphatic function, and how this function decompensates in disease, should lead to the development of new preventive and diagnostic tools and novel therapeutic targets.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s1474-4422(18)30318-1

Cites

73 of 73 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AQP4 alteration is associated with glymphatic dysfunction and increased Aβ burden.

    “Considering that AQP4 is the gold‐standard marker for astrocyte endfeet, and its alteration has been associated with glymphatic dysfunction [103] and increased Aβ burden [104]”
  • The brain glymphatic and meningeal lymphatic systems work together to clear waste and macromolecules from the brain parenchyma in homeostasis and following injury.

    “The brain glymphatic and meningeal lymphatic systems work together to clear waste and macromolecules from the brain parenchyma in homeostasis and following injury”

    From Living on the Edge of the CNS: Meninges Cell Diversity in Health and Disease (2021) · cites this paper as Rasmussen et al., 2018

  • Several lines of evidence implicate meningeal-located structures in the genesis and progression of Alzheimer's disease (AD).

    “Several lines of evidence implicate meningeal-located structures in the genesis and progression of Alzheimer’s disease (AD)”

    From Living on the Edge of the CNS: Meninges Cell Diversity in Health and Disease (2021) · cites this paper as Rasmussen et al., 2018

  • The transport of interstitial fluids and macromolecules (including amyloid-β peptides) out of the brain occurs via a complex transport network that utilizes the perivascular glymphatic system of the brain and lymphatic vessels of the meninges.

    “The transport of interstitial fluids and macromolecules (including amyloid-β peptides) out of the brain occurs via a complex transport network that utilizes the perivascular glymphatic system of the brain and lymphatic vessels of the meninges”

    From Living on the Edge of the CNS: Meninges Cell Diversity in Health and Disease (2021) · cites this paper as Rasmussen et al., 2018

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rasmussen, M. K., Mestre, H., & Nedergaard, M.
Affiliations
  • University of Copenhagen (DK)
  • University of Rochester Medicine (US)
Corresponding author
Nedergaard, Maiken
Venue
The Lancet Neurology
Publisher
Elsevier BV
Published
2018-11
Volume
17
Issue
11
Pages
1016-1024
ISSN
1474-4422 (ISSN-L)
OpenAlex
W2895939677
Cited by
1,560
References
73
Citations by year
2026: 249 · 2025: 291 · 2024: 206 · 2023: 174 · 2022: 251 · 2021: 176 · 2020: 138 · 2019: 73 · 2018: 1
FWCI
12.56
Type
journal article
Language
en
Open access
Locations
  • The Lancet Neurology (publishedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, other-oa)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute of Neurological Disorders and Stroke
  • Novo Nordisk Fonden
  • Cure Alzheimer's Fund
  • National Institutes of Health (R01NS100366, RF1AG057575)
  • EU Joint Programme – Neurodegenerative Disease Research
  • Fondation Leducq
  • Lundbeckfonden
  • National Institute on Aging
  • Horizon 2020 (666881)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Cerebrospinal fluid and hydrocephalus
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ion Transport and Channel Regulation
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
meningeal lymphatic system, aquaporin-4, cerebrospinal fluid clearance, amyloid-beta, sleep, Alzheimer's disease, traumatic brain injury, stroke, normal pressure hydrocephalus, cerebrospinal fluid flow, glymphatic dysfunction, neurodegeneration, brain interstitial fluid, sleep deprivation
MeSH terms
Glymphatic System, Humans, Nervous System Diseases

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review